|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/404 | |||
| C07K 14/47 | |||
| C12N 9/48 | |||
| C12N 9/64 | |||
| A61K 9/00 | |||
| A61K 31/7088 | |||
| C07K 16/28 | |||
| C07K 16/30 | |||
| A61K 39/00 |
| (11) | Number of the document | 2844282 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13729083.9 |
| Date of filing the European patent application | 2013-04-29 | |
| (97) | Date of publication of the European application | 2015-03-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2013/053377 |
| Date | 2013-04-29 |
| (87) | Number | WO 2013/164754 |
| Date | 2013-11-07 |
| (30) | Number | Date | Country code |
| 201261642844 P | 2012-05-04 | US |
| (72) |
BINDER, Joseph John, US
CHO, Helen Kim, US
DERMYER, Michael Robert, US
JOOSS, Karin Ute, US
PIERCE, Brian Gregory, US
TAN, Joyce Tsi, US
TSAI, Van To, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | PROSTATE-ASSOCIATED ANTIGENS AND VACCINE-BASED IMMUNOTHERAPY REGIMENS |
| PROSTATE-ASSOCIATED ANTIGENS AND VACCINE-BASED IMMUNOTHERAPY REGIMENS |